The ASX slid hard at lunch with banks, energy and property all in the red, gold soaring to fresh records and ANZ swinging the axe.
Artrya is seeking to raise $80 million in a placement and share purchase plan, to support the rollout of its heart disease diagnosis tools.
Orthocell receives 81.1% treatment success rate for nerve repair device, Remplir, in new real-world study.
Some have crashed and burned but other alternative investments, like gold, continue to shine. Experts say there’s a limit to how much you should hold.
Astral Resources has identified bedrock gold of up to 26m at 2g/t at the new Spargoville project which abuts its flagship Mandilla project.
